Baird raises target for Cencora stock from USD 370 to USD 373

Published on 10/13/2026 at 12:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fiscal third-quarter revenue rose 5.10 percent to USD 84.80 billion. Cencora stock costs EUR 290.85 on October 13, 2026.

Robert W. Baird raised its Cencora price target from USD 370.00 to USD 373.00 on October 12, 2026.
Fiscal third-quarter revenue increased 5.10 percent to USD 84.80 billion for the period ended June 30, 2026.
Cencora stock was trading at EUR 290.85 at Lang & Schwarz on October 13, 2026 at 12:34 p.m. CEST.
Cencora plans to release fiscal fourth-quarter results on November 4, 2026, before the NYSE open.

Luftbild eines modernen Pharma-Lagerzentrums mit Lieferfahrzeugen und Verladedocks — Cencora Inc. betreibt US15135B1017 ein großes Pharmadistributionszentrum mit Lastwagen Gabelstaplern und täglicher Medikamentenlogistik, Illustration mit AI erstellt.

Cencora stock (ISIN US03073E1055) was trading at EUR 290.85 at Lang & Schwarz on October 13, 2026 at 12:34 p.m. CEST. Robert W. Baird raised its price target from USD 370.00 to USD 373.00 on October 12, 2026, according to Yahoo Finance. The move gives the stock a fresh analyst reference as investors await the next results date.

What does the latest quarter show?

In the fiscal third quarter ended June 30, 2026, Cencora reported revenue of USD 84.80 billion, up 5.10 percent from the prior-year quarter, according to Business Wire. GAAP diluted earnings per share reached USD 3.94, compared with USD 3.52 in the fiscal third quarter of 2025, a USD 0.42 increase.

The quarterly figures show the scale of Cencora's distribution business, but the earnings comparison is the sharper signal for operating progress. Cencora serves pharmaceutical manufacturers, hospitals, pharmacies and other healthcare providers through distribution, commercialization and patient-access services.

Three dated developments

On August 5, 2026, Cencora reported fiscal third-quarter revenue of USD 84.80 billion. On September 25, 2026, Business Wire reported the election of Robert E. Sanchez as an independent director, effective October 1, 2026. On October 12, 2026, Baird raised its target from USD 370.00 to USD 373.00, according to Yahoo Finance.

Next date is November 4

Cencora plans to release fiscal fourth-quarter 2026 results before the opening of trading on the New York Stock Exchange on November 4, 2026, with an 8:30 a.m. ET conference call, according to Morningstar. That release will provide the next reported test of the company's fiscal 2026 performance and its earnings outlook.

Stock price and investor context

At Lang & Schwarz, Cencora stock was trading at EUR 290.85 on October 13, 2026 at 12:34 p.m. CEST. The company had a market capitalization of USD 63.2 billion and a 52-week range of USD 244.82 to USD 377.54 as of October 12, 2026; on the NYSE, Cencora is identified by ticker COR. The further course of trading is shown by the continuously updated real-time quote of Cencora stock.